logo
Viking DNA helps reveal when HIV-fighting gene mutation emerged: 9,000 years ago near the Black Sea

Viking DNA helps reveal when HIV-fighting gene mutation emerged: 9,000 years ago near the Black Sea

Yahoo13-05-2025
When you buy through links on our articles, Future and its syndication partners may earn a commission.
A gene variant that helps protect people from HIV infection likely originated in people who lived during the span of time between the Stone Age and the Viking Age, a new study of thousands of genomes reveals.
"It turns out that the variant arose in one individual who lived in an area near the Black Sea between 6,700 and 9,000 years ago," Simon Rasmussen, a bioinformatics expert at the University of Copenhagen and co-senior author of the study, said in a statement. The variant must have been helpful for something else in the past, since HIV in humans is less than a century old.
In a study published May 5 in the journal Cell, Rasmussen and his colleagues detailed their search for the origin of a genetic mutation known as CCR5 delta 32. CCR5 is a protein predominantly found in immune cells that many — but not all — HIV strains use to break into those cells and trigger infection.
But in people with two copies of the CCR5 delta 32 mutation, the protein gets disabled, essentially "locking out" the HIV virus. Scientists have taken advantage of this mutation to cure a handful of people of HIV.
Related: Mysterious case of the 'Geneva patient,' the latest person in long-term remission from HIV, raises questions
Scientists have learned that this variant makes up 10% to 16% of CCR5 genes seen in European populations. However, attempts to identify its origin and trace its spread have previously come up short, since ancient genomes are often extremely fragmentary.
In the new study, the research team identified the mutation in 2,504 genomes from modern humans sampled for the 1000 Genomes Project, an international effort to catalog human genetic variation. Then, they created a model to search 934 ancient genomes from various regions of Eurasia ranging from the early Mesolithic period to the Viking Age, from roughly 8000 B.C. to A.D. 1000.
"By looking at this large dataset, we can determine where and when the mutation arose," study co-author Kirstine Ravn, a researcher at the University of Copenhagen, said in the statement.
The team's genetic detective work revealed that the person who first carried this mutation lived near the Black Sea around 7000 B.C., around the time early farmers arrived in Europe via Western Asia. The researchers also discovered that the prevalence of the mutation exploded between 8,000 and 2,000 years ago, suggesting it was extremely useful as people moved out of the Eurasian steppe.
The study's findings contradict previous assumptions that the mutation emerged more recently. For instance, this means that the increase in the frequency of the mutation did not result from medieval plagues or from Viking exploration, which may have introduced pressure for humans' immune cells to evolve.
When it's not being ransacked by HIV, the CCR5 protein helps control how immune cells respond to signals called chemokines, likely helping direct cells to sites of inflammation in the body.
RELATED STORIES
—1,500 ancient European genomes reveal previously hidden waves of migration, study finds
—Ancient hunter-gatherer DNA linked to higher BMI in modern Japanese people
—Ancient DNA and modern genomes can reveal stories of past peoples, from the Iron Age to Chernobyl, geneticist says
The researchers suggest that people who carried the special CCR5 variant had an advantage. "People with this mutation were better at surviving, likely because it dampened the immune system during a time when humans were exposed to new pathogens," study co-author Leonardo Cobuccio, a postdoctoral researcher at the University of Copenhagen, said in the statement. While this sounds negative, an overly aggressive immune system can be deadly, he said — when facing new germs, you want just enough of an immune response to subdue the threat without hurting the body itself.
"As humans transitioned from hunger-gatherers to living closely together in agricultural societies," Cobuccio said, "the pressure from infectious diseases increased, and a more balanced immune system may have been advantageous." Of course, this is a hypothesis; the exact pressures that lead to the variant's increase aren't known for sure.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Legendary Hacker & Investor Pablos Holman's 1000x Deep Tech Future
Legendary Hacker & Investor Pablos Holman's 1000x Deep Tech Future

Forbes

time4 hours ago

  • Forbes

Legendary Hacker & Investor Pablos Holman's 1000x Deep Tech Future

Pablos Holman is a hacker, writ large. The first time he spoke for one of my events, in 2010, he captured an audience member's credit card information during a break and started making a purchase on stage. He didn't complete the purchase (or share the number), but he did make his point. When I'm puzzling over a truly far-out concept or epochal challenge, Holman is one of my go-to experts. He's spent his career hacking humanity's biggest challenges with organizations like Blue Origin and Intellectual Ventures. His new book, Deep Future, is a field guide to transformative technology and paradigm-shattering thinking. Fellow Technologists: 'Aim Higher!' Holman calls himself a 'Possibilist'—the future can be better, if we decide to build it. That ethos threads the book and echoes a theme I've written about for years: technology as the art of the possible. To do this well requires reframing problems, escaping established paradigms, and doing the hard work of real invention. Deep Future draws a sharp line between 'shallow tech' and 'deep tech.' Shallow tech enhances convenience. He bluntly proposes, 'If somebody makes an iPhone app to have weed delivered to their dorm room using drones, do we really have to call that tech?' Deep tech expands human capability by orders of magnitude. Holman challenges us: stop chasing 1% gains. 'Deep Tech is about finding the breakthroughs that make it possible to do things 10x, 100x, 1,000x faster, cheaper or better.' Mosquitoes Meet Lasers If you know Pablos, you know about the mosquito-zapping laser invented at Nathan Myhrvold's Intellectual Ventures. The team took apart the malaria problem and tried something new: detect the wingbeat frequency—to distinguish it from other insects—of a female Anopheles in flight and shoot it down. 'We can, and will, eradicate malaria once and for all in our lifetimes. But not by reading the directions,' he the problem, prototype shamelessly and let physics do the heavy lifting. When the approach works—even once—you've expanded what's possible. The mosquito laser array wasn't intended to go to market. Many deep tech visions are. Read the book for dozens of compelling cases. Here are three. Deep Future relates the story of Holman's fund investing in Ladon Robotics, a company reenvisioning ocean-going shipping around autonomy and wind. Consider the economics: 'About five out of six dollars spent on a ship during its life is burned as fuel. This industry literally burns most of its operational expenditures.' Ladon's idea is deceptively simple: autonomous ships powered by wind, with sun-powered battery auxiliary propulsion for navigating harbors and periods with low winds. In other words, remove fuel from the costs. It's classic deep tech. It doesn't 'improve' shipping, it transforms it. Renewables stumble on intermittency and storage. Holman proposes to ensure the sun never sets on your solar farm. 'Put those solar panels on a rocket ship, blast them into space.' Orbital solar farms could intercept sunlight 24/7, receiving eight times as much energy as they would on the Earth's surface. The system could deliver electricity via radio waves to receiving antennas on the ground, 'even in the middle of the night or during a snowstorm.' A decade ago, this would have read like a comic book. Falling launch costs and mature RF beam-forming technologies make this increasingly feasible. Holman argues, 'All the technology to do this exists already. No breakthroughs necessary.' It's a plausible path to low-cost power—precisely the kind of paradigm flip deep tech is meant to deliver. While others have proposed such a solution, Holman's venture firm Deep Future has invested in Virtus Solis, a team endeavoring to make it happen. Some of the best solutions have been around for centuries. Consider concrete, civilization's foundation and one of our dirtiest materials. Holman highlights the work of MIT's Admir Masic, which helps explain why Ancient Rome's Pantheon still stands: lime clasts throughout Roman concrete act as self-healing reservoirs. 'When water seeps in, it activates the lime and fills the cracks. It is self-healing concrete that gets stronger with time.' Longer-lasting infrastructure with 10% - 50% lower lifecycle carbon emissions. With cement accounting for approximately 8% – 13% of global CO₂ emissions, this matters. Unlike most deep tech solutions, this one has thousands of years of proof behind it. Massive Thinking, Brutal Simplicity Holman's examples—mosquito lasers, autonomous shipping, space-based solar, self-healing concrete--exhibit how to see differently: select huge problems that matter, don't let current reality get in the way, discover opportunities the incumbents ignore. While Deep Future is about audacious thinking and enormously challenging technology, much of Holman's thinking illustrates a skill I call 'brutal simplicity.' It's an approach we can all use. Here are three questions to help you do so: The first question seeks clarity before seeking solutions. Do we really understand the problem? The second tests whether we have the right problem in mind. The third question challenges us to seek as simple--though not necessarily easy--a solution as possible. Consider one of Deep Future's examples. Problem: How can we generate clean, reliable electricity at scale? Blast solar panels into space and beam the power back to Earth. Eh, voila: Virtus Solis. Ignore The Boogeymen: Build Anyway Big ideas attract bigger anxieties. Holman devotes a chapter to our habit of telling 'boogeyman' stories about new tools—nuclear, psychedelics, AI, you name it. His advice? Research, experiment, invent—then regulate the real risks we discover. The future won't be built by the skeptics. It belongs to pragmatic optimists who make better stories true. While I wouldn't expect mosquito lasers at your next BBQ, you'll likely discover a lot of you-heard-it-here-firsts in Holman's book. Thanks to the Possibilists amongst us, some of these monstrously hard, brutally simple visions will one day become reality.

This real 'Eye of Sauron' spits out ghost particles in space. Here's what it looks like
This real 'Eye of Sauron' spits out ghost particles in space. Here's what it looks like

Yahoo

time5 hours ago

  • Yahoo

This real 'Eye of Sauron' spits out ghost particles in space. Here's what it looks like

When you buy through links on our articles, Future and its syndication partners may earn a commission. For about 15 years, a powerful radio telescope on planet Earth dutifully recorded data about a location in the cosmos billions of light-years away from us — and, at last, astronomers managed to stitch together those extensive observations to reveal a full picture of what this telescope has been looking at. It's … the Eye of Sauron! Well, sort of. Though the image you're seeing bears a striking resemblance to the jarring symbol associated with the main villain in the Lord of the Rings trilogy of novels by J.R.R. Tolkien, it's actually something far more fear-inducing. At face value, at least. What you're looking at is actually a blazar, which requires a couple of layers to explain. Out in the universe, there are these things called quasars, which refer to the extremely luminous centers of active galaxies (meaning they emit a lot of electromagnetic radiation) that are powered by supermassive black holes. These galactic cores are called active galactic nuclei, or AGNs; and in fact, the monster black holes powering these phenomena can also funnel matter outward in the form of highly energetic jets of particles moving at nearly the speed of light. It's all very intense. Quasars can be so bright that they outshine the collective light of every single star in the galaxy surrounding them. Blazars, on the other hand, are pretty much quasars — except with those supermassive-black-hole-rooted jets pointing within 10 degrees of our planet. That doesn't exactly mean we're about to be obliterated by a jet, though. Remember how I said the fear remains at face value? The only reason we're seeing the jet pointing straight toward us is because of our vantage point, and this doesn't necessarily increase its danger. Still, blazars, because of this serendipitous orientation, tend to appear even brighter than the already ridiculously bright quasars. Not that it matters, but Sauron would sure love them. "When we reconstructed the image, it looked absolutely stunning," Yuri Kovalev, lead author of the study and principal investigator of the Multi-messenger Studies of Extragalactic Super-colliders project at the Max Planck Institute for Radio Astronomy (MPIfR), said in a statement. "We have never seen anything quite like it — a near-perfect toroidal magnetic field with a jet, pointing straight at us." "This alignment causes a boost in brightness by a factor of 30 or more," explains Jack Livingston, a study co-author at MPIfR. "At the same time, the jet appears to move slowly due to projection effects — a classic optical illusion." And this particular blazar could be the one blazar to rule them all. Scientists have formed a clear image of it using observations from the Very Long Baseline Array (named PKS 1424+240), and it may very well be one of the brightest sources of high-energy gamma rays and cosmic neutrinos ever observed. Neutrinos are mind-blowing items themselves, while we're at it. They're nicknamed "ghost particles" because they're invisible, zippy bits that penetrate the entirety of our cosmos yet remain tremendously difficult to detect. Trillions of these particles are flowing through your body as you read this, but you can't tell because they don't interact with any of the particles that make up your body. They slide right through. The IceCube Neutrino Observatory near the South Pole, specifically built to pin down neutrinos, is actually the institution that discovered PKS 1424+240 in the first place because of its super high neutrino emission levels. Solving this puzzle confirms that active galactic nuclei with supermassive black holes are not only powerful accelerators of electrons, but also of protons — the origin of the observed high-energy neutrinos," concludes Kovalev. Reconstructing the spectacular blazar, according to the discovery team, also allows astronomers to peer directly into the "heart" of this jet — and that could be great news for scientists trying to understand the dynamics of these awesome objects. Kovalev explains that it confirms AGNs with supermassive black holes don't only accelerate electrons (negatively charged particles that make up atoms) but also protons. This is a big find, the researcher explains, because that explains the origin of the high-energy neutrinos PKS 1424+240 appears to be spitting out. A study about these results was published on Tuesday (Aug. 12) in the journal Astronomy & Astrophysics Letters. Solve the daily Crossword

Abbott, Siemens Healthineers, and Thermo Fisher Scientific Lead the Market with Innovative Portfolios and Strategic Expansion
Abbott, Siemens Healthineers, and Thermo Fisher Scientific Lead the Market with Innovative Portfolios and Strategic Expansion

Yahoo

time5 hours ago

  • Yahoo

Abbott, Siemens Healthineers, and Thermo Fisher Scientific Lead the Market with Innovative Portfolios and Strategic Expansion

The HIV Diagnostics Companies Quadrant report offers an in-depth analysis of the global HIV diagnostics market, assessing over 100 companies and highlighting the Top 14 leaders. Market expansion is driven by rising HIV/AIDS prevalence, point-of-care technological advancements, and awareness campaigns. However, high costs and skilled technician shortages hinder growth. North America leads in market dominance due to its HIV/AIDS prevalence and advanced technologies, while Asia Pacific is projected to grow fastest. Key players like Abbott, Siemens Healthineers, and Thermo Fisher Scientific employ strategies like acquisitions and innovations to maintain strong market positions amid evolving trends. Dublin, Aug. 14, 2025 (GLOBE NEWSWIRE) -- The "HIV Diagnostics - Company Evaluation Report, 2025" report has been added to HIV Diagnostics Companies Quadrant is a comprehensive industry analysis that provides valuable insights into the global market for HIV Diagnostics. This quadrant offers a detailed evaluation of key market players, technological advancements, product innovations, and emerging trends shaping the industry. 360 Quadrants evaluated over 100 companies, of which the Top 14 HIV Diagnostics Companies were categorized and recognized as the quadrant growth can be attributed to the rising prevalence of HIV/AIDS, the advantages offered by point-of-care instruments & kits, and increasing initiatives for HIV awareness campaigns. However, the high cost of NATs, operational barriers, and the shortage of skilled laboratory technicians are key factors restraining the market growth. The high growth potential of emerging economies and the trend of self-testing are expected to provide lucrative opportunities for market players during the forecast HIV diagnostics market is segmented into six regions: North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries. North America dominated the global market in 2023. Factors such as the rising prevalence of HIV/AIDS, advancements in PoC instruments and kits, increasing awareness about HIV/AIDS, and increasing blood transfusion and blood donations are driving the growth of the HIV diagnostics market in North the Asia Pacific market is expected to grow at the highest CAGR during the forecast period. The high growth rate of the Asia Pacific market can be attributed to the rising target patient population; the expansion of emerging economies; the increasing availability of technologically advanced POC products; favorable government initiatives for HIV awareness; and the growing expansion of global players in this Players:Key players in this market include Abbott (US), Siemens Healthineers AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland). These players adopt various strategies, such as product launches, expansions, acquisitions, and collaborations, to excel in this (US)Abbott is a leading player in the HIV diagnostics market, known for its impactful Company Product Portfolio that includes FDA- and CE-approved products. The company's strong Company Market Share in the U.S. is complemented by its strategic focus on expanding its presence in emerging markets through varied Company Positioning strategies. By leveraging inorganic growth strategies, such as collaborations and acquisitions, Abbott aims to bolster its Company Healthineers AG (Germany)Siemens Healthineers is a cornerstone in the HIV diagnostics sphere, providing a broad array of medical solutions. Their focus on organic strategies and innovation has allowed them to maintain a competitive Company Positioning. With a significant presence in Europe, America, and emerging markets, they continue to excel in Company Market Share by offering innovative products that meet health sector Fisher Scientific (US)With a comprehensive Company Product Portfolio that spans PCR-based assays and immunoassays, Thermo Fisher Scientific remains a leader. Their strategies focus on regulatory approvals and strategic acquisitions to enhance their Company Market Share. Through collaboration with healthcare organizations, they aim to boost early HIV detection and improve global health access, effectively securing their Company Positioning and Company Ranking in the Topics Covered: 1 Introduction1.1 Market Definition1.2 Inclusions & Exclusions1.3 Stakeholders2 Executive Summary3 Market Overview3.1 Introduction3.2 Market Dynamics3.2.1 Drivers3.2.1.1 Rising Prevalence of Hiv/Aids3.2.1.2 Increasing Number of Blood Transfusions & Blood Donations3.2.1.3 Advantages Offered by Poc Diagnostic Kits & Instruments3.2.1.4 Increasing Initiatives for Hiv Awareness Campaigns3.2.2 Restraints3.2.2.1 High Cost of Nats3.2.3 Opportunities3.2.3.1 High Growth Potential of Emerging Economies3.2.3.2 Trend of Self-Testing and Growing Preference for At-Home Diagnostic Kits3.2.4 Challenges3.2.4.1 Operational Barriers and Shortage of Skilled Laboratory Technicians3.3 Trends/Disruptions Impacting Customers' Businesses3.4 Value Chain Analysis3.5 Supply Chain Analysis3.6 Ecosystem Analysis3.7 Technology Analysis3.7.1 Key Technologies3.7.1.1 Elisa3.7.2 Complementary Technologies3.7.2.1 Western Blot Tests3.7.3 Adjacent Technologies3.7.3.1 Pcr3.8 Patent Analysis3.9 Key Conferences & Events, 2025-20263.10 Porter's Five Forces Analysis3.10.1 Threat of New Entrants3.10.2 Threat of Substitutes3.10.3 Bargaining Power of Buyers3.10.4 Bargaining Power of Suppliers3.10.5 Intensity of Competitive Rivalry3.11 Impact of Ai/Generative Ai on Hiv Diagnostics Market3.11.1 Market Potential of Ai in Hiv Diagnostics3.11.2 Ai Use Cases3.11.3 Company Implementation of Ai3.11.4 Future of Ai/Generative Ai4 Competitive Landscape4.1 Overview4.2 Key Player Strategies/Right to Win4.2.1 Overview of Strategies Adopted by Key Players in Hiv Diagnostics Market4.3 Revenue Analysis, 2021-20234.4 Market Share Analysis, 20234.4.1 Ranking of Key Market Players4.5 Company Evaluation Matrix: Key Players, 20234.5.1 Stars4.5.2 Emerging Leaders4.5.3 Pervasive Players4.5.4 Participants4.5.5 Company Footprint: Key Players, 20234.5.5.1 Company Footprint4.5.5.2 Region Footprint4.5.5.3 Product Footprint4.5.5.4 End-User Footprint4.6 Company Evaluation Matrix: Startups/Smes, 20234.6.1 Progressive Companies4.6.2 Responsive Companies4.6.3 Dynamic Companies4.6.4 Starting Blocks4.6.5 Competitive Benchmarking: Startups/Smes, 20234.6.5.1 Detailed List of Key Startups/Sme Players4.6.5.2 Competitive Benchmarking of Key Startups/Smes4.7 Company Valuation & Financial Metrics4.8 Brand/Product Comparison4.9 Competitive Scenario4.9.1 Product/Service Launches & Approvals4.9.2 Product Launches & Approvals4.9.3 Deals4.9.4 Expansions4.9.5 Other Developments5 Company Profiles Abbott Siemens Healthineers Grifols, S.A. Danaher Corporation Thermo Fisher Scientific Inc. Bio-Rad Laboratories, Inc. F. Hoffmann-La Roche Ltd. Biomerieux Hologic, Inc. Qiagen Bd Trinity Biotech Orasure Technologies, Inc. Biosynex Sa Wondfo Getein Biotech, Inc. Meril Life Sciences Pvt. Ltd. Accubiotech Co., Ltd. Biolytical Laboratories Inc. Bio Lab Diagnostics (I) Private Limited Alpine Biomedicals Pvt Ltd. Molbio Diagnostics Pvt. Ltd. Fortress Diagnostics Advacare Pharma (Accuquik) Adaltis S.R.L. For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store